Key Details
Price
$7.77Annual Revenue
$1.05 BAnnual EPS
-$1.61Annual ROE
-10.90%Beta
0.97Events Calendar
Next earnings date:
Mar 06, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Mar 06, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
BIRMINGHAM, Ala., and DALLAS , Dec. 4, 2024 /PRNewswire/ -- On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit.
Enhabit, Inc. (NYSE:EHAB ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Jobie Williams – Senior Vice President and Treasurer Barb Jacobsmeyer – President and Chief Executive Officer Crissy Carlisle – Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies A. J. Rice – UBS Ryan Langston – TD Cowen Operator Good morning, everyone and welcome to Enhabit's Home Health and Hospice's Third Quarter, 2024 Earnings Conference Call.
Enhabit (EHAB) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.03 per share a year ago.
On September 30, 2024, Vanguard Group Inc, a prominent investment firm, executed a significant transaction involving the shares of Enhabit Inc (EHAB, Financial). The firm reduced its holdings by 626,911 shares, which adjusted its total stake in the company to 2,976,480 shares.
Enhabit, Inc. (NYSE:EHAB ) Q2 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President & CEO Crissy Carlisle - CFO Conference Call Participants Noah Erni - Jefferies Ben Rossi - Citi A.J. Rice - UBS Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's second quarter 2024 earnings conference call.
Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago.
Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enhabit (EHAB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the fil.
FAQ
- What is the primary business of Enhabit?
- What is the ticker symbol for Enhabit?
- Does Enhabit pay dividends?
- What sector is Enhabit in?
- What industry is Enhabit in?
- What country is Enhabit based in?
- When did Enhabit go public?
- Is Enhabit in the S&P 500?
- Is Enhabit in the NASDAQ 100?
- Is Enhabit in the Dow Jones?
- When was Enhabit's last earnings report?
- When does Enhabit report earnings?
- Should I buy Enhabit stock now?